BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29753273)

  • 21. Establishment of an induced pluripotent stem cell line LEIi019-A from an early-onset retinal dystrophy patient with the autosomal dominant OTX2 c.259G>A variant.
    Zhang D; Jennings L; Chen SC; Zaw K; Lamey TM; Thompson JA; McLaren TL; Chen FK; McLenachan S
    Stem Cell Res; 2024 Aug; 78():103461. PubMed ID: 38852423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
    Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of iPSC line MU011.A-hiPS from homozygous α-thalassemia fetal skin fibroblasts.
    Tangprasittipap A; Satirapod C; Jittorntrum B; Lertritanan S; Anurathaphan U; Phanthong P; Borwornpinyo S; Kitiyanant N; Hongeng S
    Stem Cell Res; 2015 Nov; 15(3):506-9. PubMed ID: 26432158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of a heterozygous COL1A1 (c.3969_3970insT) osteogenesis imperfecta mutation human iPSC line, MCRIi001-A-1, using CRISPR/Cas9 editing.
    Hosseini Far H; Patria YN; Motazedian A; Elefanty AG; Stanley EG; Lamandé SR; Bateman JF
    Stem Cell Res; 2019 May; 37():101449. PubMed ID: 31075690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman.
    Tangprasittipap A; Jittorntrum B; Wongkummool W; Kitiyanant N; Tubsuwan A
    Stem Cell Res; 2017 Apr; 20():91-93. PubMed ID: 28395748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B).
    Son D; Kang PJ; Yun W; You S
    Stem Cell Res; 2017 Oct; 24():5-7. PubMed ID: 29034895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of an iPSC line from a patient with tyrosine hydroxylase (TH) deficiency: TH-1 iPSC.
    Jung-Klawitter S; Blau N; Sebe A; Ebersold J; Göhring G; Opladen T
    Stem Cell Res; 2016 Nov; 17(3):580-583. PubMed ID: 27934587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of simultaneous reprogramming and gene correction to generate an osteogenesis imperfecta patient COL1A1 c. 3936 G>T iPSC line and an isogenic control iPSC line.
    Howden S; Hosseini Far H; Motazedian A; Elefanty AG; Stanley EG; Lamandé SR; Bateman JF
    Stem Cell Res; 2019 Jul; 38():101453. PubMed ID: 31082677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC.
    Kim BY; Jeong S; Lee SY; Lee SM; Gweon EJ; Ahn H; Kim J; Chung SK
    Exp Mol Med; 2016 Jun; 48(6):e237. PubMed ID: 27256111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
    Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
    Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of three induced pluripotent stem cell lines from a patient with Usher syndrome caused by biallelic c.949C > A and c.1256G > T mutations in the USH2A gene.
    Zaw K; Wong EYM; Zhang X; Zhang D; Chen SC; Thompson JA; Lamey T; McLaren T; De Roach JN; Wilton SD; Fletcher S; Mitrpant C; Atlas MD; Chen FK; McLenachan S
    Stem Cell Res; 2020 Dec; 50():102129. PubMed ID: 33360097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene.
    Domingo-Prim J; Riera M; Burés-Jelstrup A; Corcostegui B; Pomares E
    Stem Cell Res; 2019 Jul; 38():101468. PubMed ID: 31146251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment and characterization of an iPSC line (UCLi023-A) derived from a Late-Onset Retinal Degeneration patient carrying a founder mutation in C1QTNF5.
    Alonso-Carriazo Fernández A; Ashley-Norman P; Butt Z; Moosajee M; Carr AF
    Stem Cell Res; 2023 Jun; 69():103110. PubMed ID: 37207468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphoblast-derived integration-free iPS cell line from a female 67-year-old Alzheimer's disease patient with TREM2 (R47H) missense mutation.
    Schröter F; Sleegers K; Cuyvers E; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2016 Nov; 17(3):553-555. PubMed ID: 27789408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of two induced pluripotent stem cell lines from a patient with Stargardt disease caused by compound heterozygous mutations in the ABCA4 gene.
    Huang D; Zhang D; Chen SC; Aung-Htut MT; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Fletcher S; Wilton SD; Chen FK; McLenachan S
    Stem Cell Res; 2021 Jul; 54():102448. PubMed ID: 34198153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of two iPSC lines derived from two unrelated patients with Gaucher disease.
    Nagel M; Reichbauer J; Böhringer J; Schelling Y; Krägeloh-Mann I; Schüle R; Ulmer U
    Stem Cell Res; 2019 Mar; 35():101336. PubMed ID: 30606667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using inducible lentiviral vectors to generate induced pluripotent stem cell line ZOCi001-A from peripheral blood cells of a patient with CRB1
    Tang X; Liu X; Chen Z; Luo L; Liu X; Deng J; Li DW; Liu Y
    Stem Cell Res; 2020 May; 45():101817. PubMed ID: 32387899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of Xeno-Free, cGMP-Compliant Patient-Specific iPSCs from Skin Biopsy.
    Wiley LA; Anfinson KR; Cranston CM; Kaalberg EE; Collins MM; Mullins RF; Stone EM; Tucker BA
    Curr Protoc Stem Cell Biol; 2017 Aug; 42():4A.12.1-4A.12.14. PubMed ID: 28806854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation and characterization of two iPSC lines from human epicardium-derived cells.
    Paulitschek C; Schulze-Matz P; Hesse J; Schmidt T; Wruck W; Adjaye J; Schrader J
    Stem Cell Res; 2017 Apr; 20():50-53. PubMed ID: 28395740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.